Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 09 - 09 symbols : Abbv save search
Alvotech Announces Positive Top-Line Results for Switching Study Between Proposed Biosimilar AVT02 and Humira®
Published: 2021-09-09 (Crawled : 22:00) - biospace.com/
ABBV | News | $167.89 0.89% 0.51% 3.6M
|
Health Technology
|
| O: -0.83%
H: 0.27%
C: -1.98%
positive results topline biosimilar
Clinical Trial of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma (B-NHL) Published in The Lancet
Published: 2021-09-09 (Crawled : 14:15) - biospace.com/
ABBV | News | $167.89 0.89% 0.51% 3.6M
|
Health Technology
|
| O: -0.83%
H: 0.27%
C: -1.98%
GMAB | News | $28.97 0.94% 0.93% 2
|
Health Technology
|
| O: -1.2%
H: 0.95%
C: -0.77%
trial t-cell lancet
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
AGBA | $2.5 100.0% 58.33% 200M
|
Finance
EDBL | News | $6.26 66.49% 48.56% 270K
|
MLEC | $2.47 76.43% 38.05% 460K
|
n/a
SILO | $1.99 0.71% 20.64% 1.8M
|
Finance and Insurance
NNVC | $1.12 1.82% 19.64% 2.5K
|
Health Technology
CANG | $1.34 -4.29% 14.93% 120K
|
Technology Services
AZTR 4 | $0.195 13.85% 42K
|
n/a
TOVX | News | $0.411 -1.01% 12.9% 230K
|
Manufacturing
IBRX | $4.94 -6.26% 10.83% 4.5M
|
Manufacturing
MSTR M | $1324.01 12.77% 10.65% 26K
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.